Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features-Reference-Cited by-同舟云学术

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

Published:2016-08-09 Issue:6 Volume:64 Page:2038-2046
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Calderaro Julien¹²³,Rousseau Benoît²³⁴,Amaddeo Giuliana²³⁵,Mercey Marion²,Charpy Cécile¹,Costentin Charlotte⁵,Luciani Alain²³⁶,Zafrani Elie-Serge¹,Laurent Alexis⁷,Azoulay Daniel³⁷,Lafdil Fouad²³,Pawlotsky Jean-Michel²³⁸

Affiliation:

1. Département de Pathologie, Assistance Publique Hôpitaux de Paris; Groupe Hospitalier Henri Mondor; Créteil France

2. INSERM U955, Team 18, Institut Mondor de Recherche Biomédicale; Créteil France

3. Université Paris-Est Créteil; Créteil France

4. Service d'Oncologie Médicale; Mycologie-Parasitologie et Unité Transversale de Traitement des Infections, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor; Créteil France

5. Service d'Hépatologie; Mycologie-Parasitologie et Unité Transversale de Traitement des Infections, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor; Créteil France

6. Service d'Imagerie Médicale; Mycologie-Parasitologie et Unité Transversale de Traitement des Infections, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor; Créteil France

7. Service de Chirurgie Digestive et Hépatobiliaire; Mycologie-Parasitologie et Unité Transversale de Traitement des Infections, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor; Créteil France

8. Service de Virologie, Bactériologie-Hygiène; Mycologie-Parasitologie et Unité Transversale de Traitement des Infections, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor; Créteil France

Funder

Viruses, Immunity, and Cancers Department

Publisher

Wiley

Subject

Hepatology

Reference34 articles.

1. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;Wang;Lancet,2014

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

4. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer;J Hepatol,2012

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 334 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC;Liver International;2024-01-30

2. Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells;Scientific Reports;2024-01-19

3. Place of tyrosine kinase inhibitors in the first line of treatment of hepatocellular carcinoma;Meditsinskiy sovet = Medical Council;2024-01-18

4. C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients;World Journal of Gastrointestinal Oncology;2024-01-15

5. Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors;NAR Cancer;2024-01-09